REQUEST A DEMO
Total
USD $0.00
Search more companies

New Marketlink Pharmaceutical Corporation (Philippines)

Main Activities: Pharmacies and Drug Stores
Full name: New Marketlink Pharmaceutical Corporation Profile Updated: January 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

New Marketlink Pharmaceutical Corporation is an enterprise in Philippines, with the main office in Pasig. It operates in the Pharmacies and Drug Stores industry. It was first established on November 14, 2006. In 2022, the company reported a net sales revenue increase of 27.53%. There was a total growth of 25.64% in New Marketlink Pharmaceutical Corporation’s total assets over the same period. In 2022, New Marketlink Pharmaceutical Corporation’s net profit margin increased by 1.31%.

Legal Address
Tao Corporate Center, 90 P.E Antonio Street, Barangay Ugong, Pasig City
Pasig; National Capital Region; Postal Code: 1604

Contact Details: Purchase the New Marketlink Pharmaceutical Corporation report to view the information.

Basic Information
Outstanding Shares:
Purchase the New Marketlink Pharmaceutical Corporation report to view the information.
Financial Auditors:
Purchase the New Marketlink Pharmaceutical Corporation report to view the information.
Incorporation Date:
November 14, 2006
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CFO
Purchase this report to view the information.
Corporate Secretary
Purchase this report to view the information.
Assistant Corporate Secretary
Purchase this report to view the information.
Treasurer
Ownership Details
Purchase this report to view the information.
58.75%
Purchase this report to view the information.
12.5%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
6.25%
Company Performance
Financial values in the chart are available after New Marketlink Pharmaceutical Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
27.53%
Total operating revenue
20.19%
Operating profit (EBIT)
43.5%
Net Profit (Loss) for the Period
53.7%
Total assets
25.64%
Total equity
0.79%
Operating Profit Margin (ROS)
1.59%
Net Profit Margin
1.31%
Return on Equity (ROE)
9.04%
Debt to Equity Ratio
48.04%
Quick Ratio
0.14%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?